Submitted by Anonymous (not verified) on 4 September 2026 - 15:22
Human medicines European public assessment report (EPAR): Symtuza, darunavir,cobicistat,emtricitabine,tenofovir alafenamide, Date of authorisation: 21/09/2017, Revision: 19, Status: Authorised
Source: